Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Digital Camcorders
  9. 9. Graphics Cards
  10. 10. GPS
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Gen-Probe Incorporated



Sort by : relevance - date - popularity
4Vote!

Neogen Acquires Gen-Probe's BioKits Food Safety Business

LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated (Nasdaq: GPRO). The acquisition includes more than 50 test kits for food allergens, meat and fish speciation, and plant genetics.

+Vote!

Neogen Acquires Gen-Probe's BioKits Food Safety Business

LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated (Nasdaq: GPRO).

4Vote!

Prodesse's ProParaflu+(TM) Assay Cleared for US Marketing by FDA

SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

4Vote!

Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts

SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, December 3, 2009, at 9 a.m. Eastern Time (ET). The event will feature presentations on Gen-Probe's current business and future growth strategies by several Company executives....

4Vote!

Gen-Probe Reports Financial Results for Third Quarter 2009

SAN DIEGO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today reported financial results for the third quarter of 2009, with record product sales and total revenues driving non-GAAP earnings per share (EPS) of $0.47.

4Vote!

FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1...

4Vote!

Gen-Probe Announces Webcast of Third Quarter 2009 Earnings Conference Call

SAN DIEGO--(BUSINESS WIRE)--Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will release its third quarter 2009 financial results on Thursday, October 29, 2009 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call with management at 4:30 p.m. ET. The conference call will be webcast live and may be accessed on the investors section...

3Vote!

Gen-Probe Incorporated to Acquire Flu Test Maker, Prodesse, Inc. for $60 Million

SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO - News) announced today that it has signed a definitive agreement to acquire Prodesse, Inc., a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial...

4Vote!

Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments

SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it has signed a definitive agreement to acquire Prodesse, Inc., a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen-Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial and...

3Vote!

Gen-Probe Incorporated to Consolidate Industrial Assets Into New, Independent Company

SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq:GPRO) announced today that it is spinning off its industrial testing assetsinto a new, independent company focused on developing rapid, highly accuratemolecular assays for biopharmaceutical production, water and food safetytesting, and other applications. Gen-Probe initially will own 19.9% of the new company...

4Vote!

Millipore and Roka Bioscience to Develop Real-Time Molecular Tests for Biopharmaceutical Applications

BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it will collaborate with Roka Bioscience, Inc. to develop molecular assays and portable instruments for biopharmaceutical production. As recently announced by Gen-Probe Incorporated (NASDAQ: GPRO), Roka Bioscience is a...

5Vote!

Gen-Probe to Webcast Four Upcoming Investor Presentations

SAN DIEGO, Sept. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the following investor conferences: Baird's 2009 Health Care Conference in New York at 2:45 p.m.

3Vote!

Gen-Probe Incorporated Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO - News) announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy. "Based on the results of our extensive clinical research studies and our European commercial...

3Vote!

Gen-Probe Begins U.S. Clinical Study Of APTIMA(R) Trichomonas Vaginalis Assay On The TIGRIS(R) System

Gen-Probe Incorporated (Nasdaq: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its APTIMA((R)) assay for Trichomonas vaginalis on the fully automated TIGRIS((R)) system.

5Vote!

Gen-Probe Begins U.S. Clinical Study of APTIMA(R) Trichomonas Vaginalis Assay on the TIGRIS(R) System

SAN DIEGO, Aug. 17 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has begun a clinical trial intended to secure U.S.

The last article published by a user on Gen-Probe Incorporated :

3Vote!

Gen-Probe Incorporated - Financial and Strategic Analysis Review

Gen-Probe Incorporated - Financial and Strategic Analysis Review    - aarkstore

Summary Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marketing of nucleic acid tests (NATs), principally used to diagnose human diseases and screen donated human blood. The company principally operates in North America. It is headquartered in California, United States and employs 1,049 people. The company’s subsidiaries include Gen-Probe Sales & Service, Inc., Delaware;...